{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:05:48Z","timestamp":1793862348896,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR302961"],"award-info":[{"award-number":["NIHR302961"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clinme.2026.100608","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:58:06Z","timestamp":1782143886000},"page":"100608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heart failure with preserved ejection fraction (HFpEF): Diagnosis and management for the general physician"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-3693","authenticated-orcid":false,"given":"Rosita","family":"Zakeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-1492","authenticated-orcid":false,"given":"Adam A.","family":"Nabeebaccus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2026.100608_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinme.2026.100608_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(84)80207-6","article-title":"Congestive heart failure with normal systolic function","volume":"54","author":"Dougherty","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinme.2026.100608_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.clinme.2026.100608_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag030","article-title":"Heart failure in the Portuguese population aged >\/=50 years: prevalence and phenotypes in the PORTHOS study","author":"Baptista","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinme.2026.100608_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2019.05.052","article-title":"Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction","volume":"74","author":"Tromp","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinme.2026.100608_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/heartjnl-2017-312183","article-title":"Routes to diagnosis of heart failure: observational study using linked data in England","volume":"104","author":"Bottle","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.clinme.2026.100608_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/heartjnl-2016-310790","article-title":"Heart failure with preserved ejection fraction: controversies, challenges and future directions","volume":"104","author":"Zakeri","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.clinme.2026.100608_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinme.2026.100608_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11897-015-0267-3","article-title":"Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction","volume":"12","author":"Zakeri","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.clinme.2026.100608_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.clinme.2026.100608_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102822","article-title":"Evolutionary history of the comorbidity-driven coronary microvascular endothelial inflammation hypothesis and its metamorphosis to the adipokine hypothesis of heart failure with a preserved ejection fraction","volume":"14","author":"Packer","year":"2026","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102644","article-title":"Resting hemodynamics and prognosis in heart failure with preserved ejection fraction","volume":"13","author":"Mohammed","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib15","unstructured":"National Institute for Health and Care Excellence (NICE). Chronic heart failure in adults: diagnosis and management [NG106];\u00a02018. \u3008https:\/\/www.nice.org.uk\/guidance\/ng106\u3009. updated 3 September 2025. Accessed 03 April 2026."},{"key":"10.1016\/j.clinme.2026.100608_bib16","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.clinme.2026.100608_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s44156-024-00051-2","article-title":"The assessment of left ventricular diastolic function: guidance and recommendations from the British Society of Echocardiography","volume":"11","author":"Robinson","year":"2024","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.clinme.2026.100608_bib18","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1002\/ehf2.13532","article-title":"Applying the ESC 2016, H(2) FPEF, and HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population","volume":"8","author":"Nikorowitsch","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jchf.2024.01.015","article-title":"Utility and validity of the HFA-PEFF and H(2)FPEF scores in patients with symptomatic atrial fibrillation","volume":"12","author":"Ariyaratnam","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinme.2026.100608_bib21","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinme.2026.100608_bib22","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.clinme.2026.100608_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jjcc.2025.03.018","article-title":"An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: the BREATH(2) score","volume":"86","author":"Saito","year":"2025","journal-title":"J Cardiol"},{"key":"10.1016\/j.clinme.2026.100608_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.clinme.2026.100608_bib25","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinme.2026.100608_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib27","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.clinme.2026.100608_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib32","unstructured":"National Institute for Health and Care Excellence (NICE). Finerenone for treating chronic kidney disease in type 2 diabetes. Technology appraisal guidance [TA877];\u00a02023. \u3008https:\/\/www.nice.org.uk\/guidance\/ta877\u3009. Accessed 17 April."},{"key":"10.1016\/j.clinme.2026.100608_bib33","unstructured":"National Institute for Health and Care Excellence (NICE). Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]. Technology appraisal in development. \u3008https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-ta11651\u3009. Accessed 17 April."},{"key":"10.1016\/j.clinme.2026.100608_bib34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib35","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clinme.2026.100608_bib36","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib37","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","article-title":"Effect of beta-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction","volume":"78","author":"Palau","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinme.2026.100608_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","article-title":"Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials","volume":"8","author":"Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib39","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2020.26812","article-title":"Effect of high-intensity interval training, moderate continuous training, or guideline-based physical activity advice on peak oxygen consumption in patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"325","author":"Mueller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clinme.2026.100608_bib40","volume":"15","author":"Taylor","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinme.2026.100608_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clinme.2026.100608_bib42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100608_bib45","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.clinme.2026.100608_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCHEARTFAILURE.113.000568","article-title":"Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"7","author":"Zakeri","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/ejhf\/xuag153","article-title":"Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials","author":"Mendieta","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinme.2026.100608_bib48","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","article-title":"Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure","volume":"145","author":"Borlaug","year":"2022","journal-title":"Circulation"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:22Z","timestamp":1786136002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211826000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1470211826000576"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100608","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure with preserved ejection fraction (HFpEF): Diagnosis and management for the general physician","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100608"}}